Creative Diagnostics Launches Portfolio of Environmental Toxicology Biomarker Antibodies to Support Biological Research

Sep 22, 2026

Creative Diagnostics launches Environmental Toxicology Biomarker Antibodies to support researchers in investigating the biological effects of chemical exposure in aquatic organisms and wildlife.

New York, NY, United States, September 22, 2026 /MarketersMEDIA/ -- Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of its specialized portfolio of Environmental Toxicology Biomarker Antibodies, which can support researchers in investigating the biological effects of chemical exposure in aquatic organisms and wildlife. This targeted product line will enable scientists to gain deeper insights into areas such as aquatic toxicology, ecotoxicology monitoring, and wildlife health research.

Biomarkers are important parameters that are reliable, applicable, reproducible and typically low-cost. They play a significant role in human health, particularly mechanistic biomarkers, which are of the utmost importance for preventing toxic effects and diseases. They can reflect the diagnosis, prognosis, recurrence and progression of diseases. Furthermore, they can indicate the level of human exposure to various chemical, biological and physical factors. Until now, developing and applying biomarkers has required an understanding of the underlying mechanisms involved in their production.

Biomarkers of environmental toxins can be used to measure exposure and effects, and some can be used to assess disease risk and susceptibility among individuals. Metabolites, proteins and DNA adducts can also help to elucidate the mechanisms of bioactivation and detoxification of toxic intermediates. Certain environmental chemicals act as modulators of gene and protein activity, inducing microbiome dysbiosis and affecting the metabolome and overall health.

To support these needs and accelerate scientific research, Creative Diagnostics now offers a range of monoclonal and polyclonal antibodies for environmental toxicology biomarker research. The portfolio covers key targets associated with exposure and effects, such as CYP1A, vitellogenin (Vtg), metallothionein (MT) and zonulin (Zrp). They can react with common research fish, including rainbow trout, Atlantic salmon, Atlantic cod, carp, flounder, zebrafish, bluegill, killifish and three-spined stickleback, as well as specific wildlife models such as alligators and birds.

For example, Creative Diagnostics now offers the Mouse anti-fish CYP1A peptide Monoclonal antibody (Catalog # CABT-L1857W) for ELISA and WB applications. This antibody can cross-react with CYP1A in liver samples from various fish species, including rainbow trout (Oncorhynchus mykiss), Atlantic salmon (Salmo salar), carp (Cyprinus carpio), halibut (Scophthalmus maximus) and Atlantic cod (Gadus morhua). The extent of cross-reactivity varies depending on the species and the method used. This product has performed well in ELISA and Western blot experiments across multiple species, as well as in immunohistochemical experiments. As detection conditions vary, the optimal dilution ratio must be determined for each application.

Creative Diagnostics' environmental toxicology biomarker antibodies can support researchers in assay development, biomarker monitoring, comparative biology, ecotoxicological testing, and contaminant impact assessments. For detailed product specifications, species cross-reactivity data, or to explore the complete catalog, please visit https://www.creative-diagnostics.com/environmental-toxicology-biomarker-antibodies.htm.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. In addition to providing contract R&D and biologic manufacturing services for diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market, the company aims to continue to act as a trusted source for all researchers' assay development and manufacturing needs.

Contact Info:
Name: Thomas Schmitt
Email: Send Email
Organization: Creative Diagnostics
Website: https://www.creative-diagnostics.com/

Release ID: 89204004

In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.

More News

European pharma chiefs warn region risks losing ground to America, China
Sep 22, 2026
European pharma chiefs warn region risks losing ground to America, China

Drugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a disparity in access with the US, unless the region's healthcare systems agree to boost spending.

Afghan cyclist Fariba Hashimi who disguised herself as man wins Asian Games silver
Sep 22, 2026
Afghan cyclist Fariba Hashimi who disguised herself as man wins Asian Games silver

Afghan cyclist Fariba Hashimi won a silver medal in the women's road race at the Asian Games near Nagoya, Japan, after overcoming restrictions on women in Afghanistan and leaving the country following the Taliban's return to power in 2021. Hashimi, who once trained disguised as a man, said she hoped her medal would inspire Afghan women and future generations to pursue their dreams without fear.

Iran is waiting to see how I do in mid-term election: Trump
Sep 22, 2026
Iran is waiting to see how I do in mid-term election: Trump

Trump called for the complete economic isolation of Iran in his UN speech, while saying he expected a deal with Tehran after the November midterm elections. Iran said it could reopen the Strait of Hormuz within seven days if US military pressure and the blockade on Iranian ports were eased. Trump also described Cuba as a failed state.

UK to provide Saudi Arabia defensive air-refuelling support against Houthis
Sep 22, 2026
UK to provide Saudi Arabia defensive air-refuelling support against Houthis

The UK has decided to assist Saudi Arabia's military by providing defensive air-to-air refueling support. This agreement follows a request made by Saudi Arabia to enhance their operational capabilities against the Houthi militants. Prime Minister Andy Burnham confirmed that this military help would be the first of its kind from a foreign country. Saudi Arabia has also sought similar support from the Americans to bolster their defenses.

US midterm elections 2026: A new Congress could change Trump's legislative agenda; what house control means for Washington
Sep 22, 2026
US midterm elections 2026: A new Congress could change Trump's legislative agenda; what house control means for Washington

US midterm elections 2026: Forecasts suggest that Democrats could clinch around 226 seats in the House during the 2026 midterm elections, while the Senate election is shaping up to be a tightly contested affair. This period will be pivotal for Congress as it navigates funding the government and raising the debt ceiling for President Trump.

'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gap
Sep 22, 2026
'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gap

Supreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a serious issue for patients and taxpayers. The bench said such disparities could lead to excessive costs under government health schemes and sought greater scrutiny of medicine pricing. The court was hearing a petition on generic prescriptions and price controls.

'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gap
Sep 22, 2026
'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gap

Supreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a serious issue for patients and taxpayers. The bench said such disparities could lead to excessive costs under government health schemes and sought greater scrutiny of medicine pricing. The court was hearing a petition on generic prescriptions and price controls.

Maharashtra drought deepens, crop output crisis mounts
Sep 22, 2026
Maharashtra drought deepens, crop output crisis mounts

State agriculture minister Dattatray Bharane has confirmed a large contraction in the production of cotton and soybean, while the agriculture department has initiated an early crop assessment to calculate compensation as farmers are removing wilted crops from fields.

DNA reveals four gentoo penguin species instead of one after more than 100 years. Scientists now fear some island populations could lose their homes to global warming
Sep 22, 2026
DNA reveals four gentoo penguin species instead of one after more than 100 years. Scientists now fear some island populations could lose their homes to global warming

New genomic research has resolved a century-old debate over gentoo penguins, revealing four distinct species rather than one with several subspecies. The newly recognised Kerguelen gentoo lives on remote islands in the Southern Indian Ocean. Scientists warn that warming temperatures could shrink habitats for several island populations, making conservation increasingly important.

Look beyond premiumisation: FM Nirmala Sitharaman to India Inc
Sep 22, 2026
Look beyond premiumisation: FM Nirmala Sitharaman to India Inc

Sitharaman made a strong pitch for better-governed family businesses and greater corporate spending on research and development. She said the next 20 years would require Indian businesses to move beyond the creation of startups towards building enterprises that could scale, professionalise and endure.

Man tries to commit insurance fraud by setting car ablaze, blames fire on accident; arrested
Sep 22, 2026
Man tries to commit insurance fraud by setting car ablaze, blames fire on accident; arrested

Gondal Taluka police in Rajkot district have initiated proceedings against 26-year-old Deep Virdiya, who allegedly set his overturned car on fire to create the appearance of accidental damage and claim insurance money. Police said petrol was poured over the vehicle before it was ignited, while Virdiya allegedly told investigators the fire was caused by a short circuit.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Daily World Feed

Get yourself immersed in engaging topics right here. Daily World Feed is a multi-platform media, providing you latest breaking news straight from the industry.

Sign Up